[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
作者信息
Budanov S V, Vasil'ev A N, Smirnova L B
机构信息
Research Centre of Drug Evaluation and State Control, National Research Centre of Antibiotics, Moscow.
出版信息
Antibiot Khimioter. 2001;46(7):38-46.
PMID:11697244
Abstract
摘要
Zotero 插件